GLP-1s and breastfeeding: what the label says

First, breathe

If you're breastfeeding and the question of whether you could use a GLP-1 medication keeps circling back, I want to start by telling you something: asking that question does not make you a bad mom. It makes you a woman who takes care of her body and wants honest information. Let's look at it calmly, in plain words.

What the labels actually say

I went and read the current prescribing information rather than repeating what circulates, and it is more specific than a flat no.

Wegovy (semaglutide) injection. There are no data on whether injected semaglutide reaches human milk, on its effects on a nursing baby, or on milk production. The label asks that the benefits of breastfeeding be weighed against your own clinical need for the medicine³. The blunt "breastfeeding is not recommended" line on that same label belongs to the semaglutide tablet, and the reason is an absorption ingredient the injection doesn't contain³.

Ozempic (semaglutide) injection. It is the same molecule, and its label says exactly the same: no data on semaglutide in human milk, on its effects on the baby, or on milk production⁵.

Zepbound (tirzepatide). Here there's a small piece of real data. Eleven breastfeeding women were given a single 5 mg dose. Tirzepatide was undetectable in 164 of the 171 milk samples taken, and in the seven where it did show up, the total across 28 days came to under 0.02% of the mother's dose⁴. What that study can't tell you is anything about the baby, or about your milk supply. Both are still listed as unstudied⁴.

So why does everyone still say wait?

Because "very little of it gets into the milk" is not the same as "we know what it does." Reviews of weight medications in women of reproductive age land in the same place: most of them aren't recommended during pregnancy or breastfeeding, either because of a known risk to the baby or because the risk is simply unclear — and the shortage of human data makes it hard to say anything firmer².

Hold onto that distinction. "Not enough data" is not the same as "banned because it's dangerous," and it is also not the same as "safe." It's exactly why this belongs in a conversation with a clinician who knows you, and not in a comment section or a social media ad.

What the evidence shows so far

A recent systematic review gathered 36 studies of GLP-1 use before, during and after pregnancy. On the breastfeeding period it found the evidence sparse — one pharmacokinetic study, which reported no detectable semaglutide passing into human milk¹. The science is moving, but it has barely started on this stage.

That's why, for a lot of moms, the real conversation isn't "can I take it while I'm nursing?" but "when is the right time?" Many choose to wait until after they've finished breastfeeding, or to talk with their doctor about weaning and timing. Your questions here are legitimate and well-founded.

Questions to bring to your doctor

You don't need perfect words. You could simply say: "I'm breastfeeding and I'm interested in a GLP-1. What does the evidence say for my situation, and when would the right time be?" It also helps to mention:

• how long you plan to breastfeed,
• whether you're thinking about another pregnancy,
• whether your supply is already fragile, since nobody has studied what these medicines do to it,
• any health history or medications you take.

A good clinician won't rush you or make you feel judged. If that happens, you're entitled to a second opinion.

A calm next step

You don't have to decide anything today. If you'd like to understand the basics first, how to start a GLP-1, step by step will walk you through it gently.

Whatever you decide, be kind to yourself. Getting informed isn't committing to anything. — Camila

Talk with a licensed healthcare professional before making any medication decision while breastfeeding.*